References

 Ruegg C, Meuwly JY, Driscoll R, Werffeli P, Zaman K, Stupp R. The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials. Curr Mol Med. 2003 Dec;3(8):673-91. PMID: #14682490#

 Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev. 2005 Feb;15(1):102-11. PMID: #15661540#

 Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003 Jun;3(6):422-33. PMID: #12778132#

 Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003 Jun;3(6):401-10. PMID: #12778130#

 Ruoslahti E. Specialization of tumour vasculature. Nat Rev Cancer. 2002 Feb;2(2):83-90. PMID: #12635171#

 Brahimi-Horn C, Berra E, Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 2001 Nov;11(11):S32-6. PMID: #11684440#

 de Fraipont F, Nicholson AC, Feige JJ, Van Meir EG. Thrombospondins and tumor angiogenesis. Trends Mol Med. 2001 Sep;7(9):401-7. PMID: #11530335#